To assess whether FOXC2 promotes drug resistance in GC cells in vivo, we transplanted SGC7901/ADR cells stably expressing shFOXC2 or a negative control into nude mice (Supplementary Figure 2H). Here, FOXC2 is linked to gastric cancer.